Wellington Management Group LLP Y M Abs Therapeutics, Inc. Transaction History

Wellington Management Group LLP

$531 Billion
Q4 2024

A detailed history of Wellington Management Group LLP transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 133,263 shares of YMAB stock, worth $646,325. This represents 0.0% of its overall portfolio holdings.

Number of Shares

133,263

Previous 136,714 2.52%

Holding current value

$646,325

Previous $1.8 Million 41.89%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$7.76 - $15.69 $26,779 - $54,146	-3,451 Reduced 2.52%	133,263 $1.04 Million
Q3 2024 Nov 14, 2024	SELL	$9.95 - $15.39 $236,113 - $365,204	-23,730 Reduced 14.79%	136,714 $1.8 Million
Q2 2024 Aug 13, 2024	BUY	$11.6 - $17.25 $164,035 - $243,932	14,141 Added 9.67%	160,444 $1.94 Million
Q1 2024 May 15, 2024	BUY	$6.57 - $18.69 $961,210 - $2.73 Million	146,303 New	146,303 $2.38 Million
Q3 2022 Nov 14, 2022	BUY	$13.96 - $19.67 $1.09 Million - $1.54 Million	78,090 Added 4.18%	1,948,469 $28.1 Million
Q2 2022 Aug 15, 2022	SELL	$8.22 - $15.13 $330,435 - $608,210	-40,199 Reduced 2.1%	1,870,379 $28.3 Million
Q1 2022 May 16, 2022	SELL	$6.55 - $17.42 $15.5 Million - $41.1 Million	-2,360,804 Reduced 55.27%	1,910,578 $22.7 Million
Q4 2021 Feb 11, 2022	SELL	$15.51 - $29.31 $104,149 - $196,816	-6,715 Reduced 0.16%	4,271,382 $69.2 Million
Q3 2021 Nov 15, 2021	SELL	$27.47 - $37.31 $4.68 Million - $6.36 Million	-170,513 Reduced 3.83%	4,278,097 $122 Million
Q2 2021 Aug 16, 2021	BUY	$25.45 - $37.64 $36.3 Million - $53.8 Million	1,428,152 Added 47.28%	4,448,610 $150 Million
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $16.9 Million - $30.2 Million	580,649 Added 23.8%	3,020,458 $91.3 Million
Q4 2020 Feb 12, 2021	SELL	$37.86 - $54.26 $8.15 Million - $11.7 Million	-215,243 Reduced 8.11%	2,439,809 $121 Million
Q3 2020 Nov 16, 2020	BUY	$35.13 - $43.62 $11.5 Million - $14.3 Million	327,126 Added 14.05%	2,655,052 $102 Million
Q2 2020 Aug 14, 2020	SELL	$23.66 - $49.53 $9.85 Million - $20.6 Million	-416,379 Reduced 15.17%	2,327,926 $101 Million
Q1 2020 May 14, 2020	BUY	$14.39 - $35.8 $4.14 Million - $10.3 Million	287,679 Added 11.71%	2,744,305 $71.6 Million
Q4 2019 Feb 11, 2020	BUY	$23.81 - $33.78 $58.5 Million - $83 Million	2,456,626 New	2,456,626 $76.8 Million

Others Institutions Holding YMAB

# of Institutions

114

Shares Held

27M

Call Options Held

5.6K

Put Options Held

900

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $212M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Y M Abs Therapeutics, Inc. Transaction History